Mewes, C.; Alexander, T.; Büttner, B.; Hinz, J.; Alpert, A.; Popov, A.-F.; Beißbarth, T.; Tzvetkov, M.; Grade, M.; Quintel, M.;
et al. Effect of the Lymphocyte Activation Gene 3 Polymorphism rs951818 on Mortality and Disease Progression in Patients with Sepsis—A Prospective Genetic Association Study. J. Clin. Med. 2021, 10, 5302.
https://doi.org/10.3390/jcm10225302
AMA Style
Mewes C, Alexander T, Büttner B, Hinz J, Alpert A, Popov A-F, Beißbarth T, Tzvetkov M, Grade M, Quintel M,
et al. Effect of the Lymphocyte Activation Gene 3 Polymorphism rs951818 on Mortality and Disease Progression in Patients with Sepsis—A Prospective Genetic Association Study. Journal of Clinical Medicine. 2021; 10(22):5302.
https://doi.org/10.3390/jcm10225302
Chicago/Turabian Style
Mewes, Caspar, Tessa Alexander, Benedikt Büttner, José Hinz, Ayelet Alpert, Aron-F. Popov, Tim Beißbarth, Mladen Tzvetkov, Marian Grade, Michael Quintel,
and et al. 2021. "Effect of the Lymphocyte Activation Gene 3 Polymorphism rs951818 on Mortality and Disease Progression in Patients with Sepsis—A Prospective Genetic Association Study" Journal of Clinical Medicine 10, no. 22: 5302.
https://doi.org/10.3390/jcm10225302
APA Style
Mewes, C., Alexander, T., Büttner, B., Hinz, J., Alpert, A., Popov, A. -F., Beißbarth, T., Tzvetkov, M., Grade, M., Quintel, M., Bergmann, I., & Mansur, A.
(2021). Effect of the Lymphocyte Activation Gene 3 Polymorphism rs951818 on Mortality and Disease Progression in Patients with Sepsis—A Prospective Genetic Association Study. Journal of Clinical Medicine, 10(22), 5302.
https://doi.org/10.3390/jcm10225302
